Spectranetics to Participate in Upcoming Investor Conferences
August 20, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., Aug. 20, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be participating in two upcoming investor...
Spectranetics to Present at the Canaccord Genuity 34th Annual Growth Conference
July 30, 2014 16:53 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 30, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its management will be presenting at the Canaccord Genuity 34th Annual...
Spectranetics Achieves Second Quarter 2014 Revenue of $43.6 Million
July 24, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 24, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today reported financial results for the three and six months ended June 30, 2014. Highlights of...
Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis
July 23, 2014 16:27 ET
|
The Spectranetics Corporation
Turbo-Tandem® and Turbo Elite® are indicated to treat peripheral ISR,
the only on-label products in the industry
EXCITE clinical trial proves safety, efficacy of laser technology;...
AngioScore Launches New 200 mm Length AngioSculpt(R) Scoring Balloon Catheters
July 09, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 9, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that its wholly-owned subsidiary, AngioScore, Inc., developer of novel angioplasty...
Spectranetics to Hold 2014 Second Quarter Financial Results Conference Call on July 24
July 07, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., July 7, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2014 second quarter financial results after market...
Spectranetics Completes Acquisition of AngioScore Inc.
June 30, 2014 16:01 ET
|
The Spectranetics Corporation
Acquisition Expands Available Market Opportunity
Differentiated, Complementary Product Lines Combine to Provide Multiple Solutions for the Most Complex Cardiovascular Challenges
COLORADO...
![The Spectranetics Corporation logo](/news-release/logo/296916/0/296916.jpg?lastModified=12%2F10%2F2016%2000%3A45%3A44&size=2)
EXCITE Clinical Trial Data Reported at NCVH Demonstrates Acute, Superior Procedural Success
June 04, 2014 12:58 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., June 4, 2014 (GLOBE NEWSWIRE) -- A presentation by principal investigator Eric J. Dippel, MD, of Genesis Heart Institute in Davenport, Iowa, at the annual New Cardiovascular...
Spectranetics Announces Closing of $230 Million Convertible Senior Notes Offering
June 03, 2014 16:01 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., June 3, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC), a developer and manufacturer of single-use medical devices used in minimally invasive procedures...
Spectranetics Announces Pricing of $200 Million Convertible Senior Notes Offering
May 29, 2014 08:00 ET
|
The Spectranetics Corporation
COLORADO SPRINGS, Colo., May 29, 2014 (GLOBE NEWSWIRE) -- The Spectranetics Corporation (Nasdaq:SPNC), a developer and manufacturer of single-use medical devices used in minimally invasive procedures...